Capula Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capula Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.31M	Buy	25,933 +18,609	+254%	+$2.32M	0.02%	174
2025 Q4	$893K	Buy	+7,324	New	+$840K	﹤0.01%	301
2022 Q4	–	Sell	-38,171	Closed	-$3.03M	–	920
2022 Q3	$3.03M	Buy	+38,171	New	+$3.22M	0.04%	327

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capula Management's XBI Position: Q1 2026 in Review

Capula Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 254% in Q1 2026, buying an estimated $2.32M and bringing the position to 25,933 shares worth $3.31M. The position accounts for 0.02% of the portfolio, ranked #174.

Capula Management first reported a position in XBI in Q3 2022 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Capula Management held 25,933 shares of State Street SPDR S&P Biotech ETF worth $3.31M as of Q1 2026.
Capula Management bought 18,609 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.32M.
State Street SPDR S&P Biotech ETF made up 0.02% of Capula Management's portfolio in Q1 2026, its #174 holding.
Capula Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 3 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.